CAGLIO, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 123
EU - Europa 91
AS - Asia 55
SA - Sud America 2
Totale 271
Nazione #
US - Stati Uniti d'America 116
IT - Italia 47
CN - Cina 19
SG - Singapore 12
IE - Irlanda 10
CA - Canada 7
JP - Giappone 7
SE - Svezia 7
FR - Francia 6
BE - Belgio 5
GB - Regno Unito 5
IN - India 5
VN - Vietnam 4
KR - Corea 3
TR - Turchia 3
CH - Svizzera 2
ES - Italia 2
FI - Finlandia 2
HK - Hong Kong 2
PE - Perù 2
DE - Germania 1
GR - Grecia 1
NL - Olanda 1
PL - Polonia 1
RU - Federazione Russa 1
Totale 271
Città #
Chandler 22
New York 11
Dublin 10
Singapore 9
Fairfield 8
Nyköping 7
Turin 7
Milan 6
Paris 6
Medford 5
Torino 5
London 4
Rome 4
Tokyo 4
Wilmington 4
Brussels 3
Hangzhou 3
Hebei 3
Hoffman 3
Istanbul 3
Princeton 3
River Edge 3
Seoul 3
Wakagi 3
Ashburn 2
Bayonne 2
Bhilai 2
Chengdu 2
Civitella del Tronto 2
Florence 2
Lima 2
Los Angeles 2
Modena 2
Montreal 2
Pamplona 2
Pune 2
San Jose 2
Seattle 2
Toronto 2
Upper Marlboro 2
Vancouver 2
Woodbridge 2
Zurich 2
Amsterdam 1
Ancona 1
Beijing 1
Bologna 1
Bolton 1
Boston 1
Burnaby 1
Central 1
Chongqing 1
Fabriano 1
Fayetteville 1
Fiumicino 1
Genoa 1
Helsinki 1
Houston 1
Hyderabad 1
Krakow 1
Lappeenranta 1
Macerata 1
Marano di Napoli 1
Melrose 1
Nanjing 1
North Wales 1
Norwalk 1
Osimo 1
Perugia 1
Porto Recanati 1
Rockaway 1
Washington 1
Totale 206
Nome #
Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review 129
Clinical and molecular features of epidermal growth factor receptor (Egfr) mutation positive non‐small‐cell lung cancer (nsclc) patients treated with tyrosine kinase inhibitors (tkis): Predictive and prognostic role of co‐mutations 71
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab 59
Subgroup analyses in randomized phase III trials of systemic treatments in patients with advanced solid tumours: a systematic review of trials published between 2017 and 2020 10
Time trends in health-related quality of life assessment and reporting within publications of oncology randomised phase III trials: a meta-research study 6
Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study 5
Retrospective Analysis of the Correlation of MSI-h/dMMR Status and Response to Therapy for Endometrial Cancer: RAME Study, a Multicenter Experience 5
Totale 285
Categoria #
all - tutte 1.046
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.046


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 0 0 8
2021/202278 15 5 4 5 3 2 2 0 0 6 21 15
2022/202396 10 11 3 7 4 19 13 9 5 3 12 0
2023/2024103 12 8 5 11 9 10 4 9 2 22 11 0
Totale 285